Cooperative effect of serum 25-hydroxyvitamin D concentration and a polymorphism of transforming growth factor-β1 gene on the prevalence of vertebral fractures in postmenopausal osteoporosis

Journal of Bone and Mineral Metabolism

Volumn 28, Issue 4, 2010, Pages 446-450

  Mori, Seijiro ^a   Fuku, Noriyuki ^b   Chiba, Yuko ^a   Tokimura, Fumiaki ^a   Hosoi, Takayuki ^c   Kimbara, Yoshiyuki ^a   Tamura, Yoshiaki ^a   Araki, Atsushi ^a   Tanaka, Masashi ^b   Ito, Hideki ^a  

^a Tokyo Metropolitan Institute of Gerontology   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^c NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

Author keywords

Gene polymorphism; Osteoporosis; Transforming growth factor ; Vertebral fracture; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; TRANSFORMING GROWTH FACTOR BETA1; 25-HYDROXYVITAMIN D; VITAMIN D;

AGED; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; FEMALE; FRAGILITY FRACTURE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; RISK ASSESSMENT; VERTEBRA FRACTURE; VITAMIN BLOOD LEVEL; ANALOGS AND DERIVATIVES; BLOOD; GENETICS; OSTEOPOROSIS, POSTMENOPAUSAL; PHOTON ABSORPTIOMETRY; SPINAL FRACTURES; VERY ELDERLY;

ABSORPTIOMETRY, PHOTON; AGED; AGED, 80 AND OVER; FEMALE; GENOTYPE; HUMANS; OSTEOPOROSIS, POSTMENOPAUSAL; POLYMORPHISM, GENETIC; SPINAL FRACTURES; TRANSFORMING GROWTH FACTOR BETA1; VITAMIN D;

EID: 77956455289     PISSN: 09148779     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00774-009-0147-6     Document Type: Article

References (25)

1. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy (2001) Osteoporosis prevention, diagnosis, and therapy. JAMA 285:785-795
2. Orimo H, Hayashi Y, Fukunaga M, Sone T, Fujiwara M, Shiraki M, Kushida K, Miyamoto S, Soen S, Nishimura J, Oh-hashi Y, Hosoi T, Gorai I, Tanaka H, Igai T, Kishimoto H (2001) Diagnostic criteria for primary osteoporosis: year 2000 revision. J Bone Miner Metab 19:331-337
3. Peacock M, Turner CH, Econs MJ, Foroud T (2002) Genetics of osteoporosis. Endocr Rev 23:303-326
4. Albagha OM, Ralston SH (2003) Genetic determinants of susceptibility to osteoporosis. Endocrinol Metab Clin N Am 32:65-81
5. Ralston SH, de Crombrugghe B (2006) Genetic regulation of bone mass and susceptibility to osteoporosis. Genes Dev 20:2492-2506
6. Hirschhorn JN, Gennari L (2008) Bona fide genetic associations with bone mineral density. N Engl J Med 358:2403-2405
7. Hughes DE, Dai A, Tiffee JC, Li HH, Mundy GR, Boyce BF (1996) Estrogen promotes apotosis of murine osteoclast mediated by TGF-β. Nat Med 2:1132-1136
8. Yanagisawa J, Yanagi Y, Masuhiro Y, Suzawa M, Watanabe M, Kashiwagi K, Toriyabe T, Kawabata M, Miyazono K, Kato S (1999) Convergence of transforming growth factor-β and vitamin D signaling pathways on SMAD transcriptional coactivators. Science 283:1317-1321
9. Yamada Y, Hosoi T, Makimoto F, Tanaka H, Seino Y, Ikeda K (1999) Transforming growth factor beta-1 gene polymorphism and bone mineral density in Japanese adolescents. Am J Med 106:477-479
10. Yamada Y, Miyauchi A, Goto J, Takagi Y, Okuizumi H, Kanematsu M, Hase M, Takai H, Harada A, Ikeda K (1998) Association of a polymorphism of the transforming growth factor-β1 gene with genetic susceptibility to osteoporosis in Japanese women. J Bone Miner Res 13:1569-1576
11. Yamada Y, Miyauchi A, Takagi Y, Nakauchi K, Miki N, Mizuno M, Harada A (2000) Association of a polymorphism of the transforming growth factor-β1 gene with prevalent vertebral fractures in Japanese women. Am J Med 109:244-247
12. Yamada Y, Harada A, Hosoi T, Miyauchi A, Ikeda K, Ohta H, Shiraki M (2000) Association of transforming growth factor-β1 genotype with therapeutic response to active vitamin D for postmenopausal osteoporosis. J Bone Miner Res 15:415-420
13. Riggs BL (2003) Role of the vitamin D-endocrine system in the pathophysiology of postmenopausal osteoporosis. J Cell Biochem 88:209-215
14. Lips P (2001) Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 22:477-501
15. Looker AC, Mussolino ME (2008) Serum 25-hydroxyvitamin D and hip fracture risk in older US white adults. J Bone Miner Res 23:143-150
16. Cauley JA, Lacroix AZ, Wu L, Horwitz M, Danielson ME, Bauer DC, Lee JS, Jackson RD, Robbins JA, Wu C, Stanczyk FZ, LeBoff MS, Wactawski-Wende J, Sarto G, Ockene J, Cummings SR (2008) Serum 25-hydroxyvitamin D concentrations and risk for hip fractures. Ann Intern Med 149:242-250
17. Walsh MC, Hunter GR, Livingstone MB (2006) Sarcopenia in premenopausal and postmenopausal women with osteopenia, osteoporosis and normal bone mineral density. Osteoporos Int 17:61-67
18. Genant HK, Jergas M, Palermo L, Nevitt M, Valentin RS, Black D, Cummings SR (1996) Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis. J Bone Miner Res 11:984-996
19. Nishizawa Y, Nakamura T, Ohta H, Kushida K, Gorai I, Shiraki M, Fukunaga M, Hosoi T, Miki T, Chaki O, Ichimura S, Nakatsuka K, Miura M (2005) Committee on the Guidelines for the Use of Biochemical Markers of Bone Turnover in Osteoporosis Japan Osteoporosis Society: guidelines for the use of biochemical markers of bone turnover in osteoporosis (2004). J Bone Miner Metab 23:97-104
20. Tzakas P, Wong BY, Logan AG, Rubin LA, Cole DE (2005) Transforming growth factor beta-1 (TGFB1) and peak bone mass: association between intragenic polymorphisms and quantitative ultrasound of the heel. BMC Musculoskelet Disord 6:29
21. Bonewald LF (1996) Transforming growth factor-β. In: Bilezikian JP, Raisz LG, Rodan GA (eds) Principles of bone biology. Academic Press, San Diego, pp 647-659
22. Sterck JG, Klein-Nulend J, Burger EH, Lips P (1996) 1, 25-Dihydroxyvitamin D3-mediated TGF-βeta release is impaired in cultured osteoblasts from patients with multiple pituitary hormone deficiency. J Bone Miner Res 11:367-376
23. Finkelman RD, Linkhart TA, Mohan S, Lau KH, Baylink DJ, Bell NH (1991) Vitamin D deficiency causes a selective reduction in deposition of TGF-βeta in rat bone: possible mechanism for impaired osteoinduction. Proc Natl Acad Sci USA 88:3657-3660
24. Derynck R, Jarrett JA, Chen EY, Eaton DH, Bell JR, Assoian RK, Roberts AB, Sporn MB, Goeddel DV (1985) Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells. Nature (Lond) 316:701-705
25. Langdahl BL, Uitterlinden AG, Ralston SH, Trikalinos TA, Balcells S et al (2008) Large-scale analysis of association between polymorphisms in the transforming growth factor beta 1 gene (TGFB1) and osteoporosis: the GENOMOS study. Bone (NY) 42:969-981